| Identification | Back Directory | [Name]
4H-Pyrrolo[2,3-d]pyrimidin-4-one, 5-(3-chloro-4-fluorophenyl)-7-cyclopropyl-3-[2-(3-fluoro-3-methyl-1-azetidinyl)-2-oxoethyl]-3,7-dihydro- | [CAS]
2378285-59-5 | [Synonyms]
Plazinemdor
4H-Pyrrolo[2,3-d]pyrimidin-4-one, 5-(3-chloro-4-fluorophenyl)-7-cyclopropyl-3-[2-(3-fluoro-3-methyl-1-azetidinyl)-2-oxoethyl]-3,7-dihydro- | [Molecular Formula]
C21H19ClF2N4O2 | [MOL File]
2378285-59-5.mol | [Molecular Weight]
432.85 |
| Chemical Properties | Back Directory | [Boiling point ]
654.5±65.0 °C(Predicted) | [density ]
1.55±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO : 100 mg/mL (231.03 mM; Need ultrasonic) | [form ]
Solid | [pka]
-1.96±0.20(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
Plazinemdor is a N-methyl-D-aspartate(NMDA) receptor positive allosteric modulator. Plazinemdor can be uses in the research of psychiatric, neurological, and neurodevelopmental disorders, as well as diseases of the nervous system[1].. | [IC 50]
NMDA Receptor | [References]
[1] Anderson, David R, et, al. Preparation of heteroaromatic NMDA receptor modulator and uses thereof.US20200039987A. |
|
|